HCPCS Codes Similar to M1386

HCPCS Codes Similar to “M1386” Code.
Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period

G8876 Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician) Code added date: 20120101 Code effective date: 20150101 TXT \| PDF \| XML \| JSON	G8944 Ajcc melanoma cancer stage 0 through iic melanoma Code added date: 20130101 Code effective date: 20130101 TXT \| PDF \| XML \| JSON
G9831 Ajcc stage at breast cancer diagnosis = ii or iii Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9785 Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist Code added date: 20170101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON
G9786 Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist Code added date: 20170101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON	G9131 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) Code added date: 20070101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9705 Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9704 Ajcc breast cancer stage i: t1 mic or t1a documented Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9832 Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b Code added date: 20170101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G8927 Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer Code added date: 20130101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
M1390 Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1391 All patients who were diagnosed with recurrent melanoma during the current performance period Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1393 Patients who were not diagnosed with recurrent melanoma during the current performance period Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	G9071 Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON